Correction: Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors

Eusebio S. Pires _, Ryan S. D’Souza, Marisa A. Needham, Austin K. Herr, Amir A. Jazaeri, Hui Li, Mark H. Stoler, Kiley L. Anderson-Knapp, Theodore Thomas, Arabinda Mandal, Alain Gougeon, Charles J. Flickinger, David E. Bruns, Brian A. Pollok and John C. Herr

PDF  |  How to cite

Oncotarget. 2017; 8:16099-16099. https://doi.org/10.18632/oncotarget.15755

Metrics: PDF 1658 views  |   ?  

Present: The currently listed corresponding author, John C. Herr, is deceased. Oncotarget wishes to express our condolences to his family and colleagues.

Corrected: The new correspondence author information is as follows.

Original article: Oncotarget. 2015; 6(30):30194-211. DOI: 10.18632/oncotarget.4734

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15755